Optimizing the Effects of Stress Management Interventions in HIV

Health Psychology

Volumn 27, Issue 3, 2008, Pages 297-301

  O'Cleirigh, Conall ^a,b   Safren, Steven ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b The Fenway Institute at Fenway Community Health

Author keywords

HIV; immunity; psychoneuroimmunology; psychopathology; stress management interventions

Indexed keywords

ANXIETY DISORDER; ARTICLE; COMORBIDITY; HEALTH BEHAVIOR; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MENTAL DISEASE; PSYCHOSOCIAL DISORDER; STRESS MANAGEMENT;

HIV INFECTIONS; HUMANS; META-ANALYSIS AS TOPIC; PATIENT COMPLIANCE; PSYCHOLOGY; PSYCHONEUROIMMUNOLOGY; PSYCHOPATHOLOGY; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME;

EID: 47749091608     PISSN: 02786133     EISSN: None     Source Type: Journal    
DOI: 10.1037/a0012607     Document Type: Article

References (42)

1. Antoni M.H., Carrico A.W., Durán R.E., Spitzer S., Penedo F., Ironson G., Fletcher M.A., Klimas N., and Schneiderman N. Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy. Psychosomatic Medicine 68 (2006) 143-151
2. Antoni M.H., Cruess D., Klimas N., Maher K., Cruess S., Kumar M., Lutgendorf S., Ironson G., Schneiderman N., and Fletcher M.A. Stress management and immune system reconstitution in symptomatic HIV-infected gay men over time: Effects on transitional naïve T-cells (CD4+CD45RA+CD29+). American Journal of Psychiatry 159 (2002) 143-145
3. Antoni M.H., Cruess D., Klimas N., Maher K., Cruess S., Lechner S., Carrico A., Kumar M., Lutgendorf S., Ironson G., Fletcher M.A., and Schneiderman N. Increases in a marker of immune system reconstitution are predated by decreases in 24-hour urinary cortisol output and depressed mood during a 10-week stress management intervention in symptomatic gay men. Journal of Psychosomatic Research 58 (2005) 3-13
4. Antoni M.H., Cruess D., Cruess S., Wagner S., Lutgendorf S., Kumar M., Ironson G., Klimas N., Fletcher M.A., and Schneiderman N. Cognitive behavioral stress management effects on anxiety, 24-hour urinary catecholamine output, and T-cytotoxic/suppressor cells over time among symptomatic HIV-infected gay men. Journal of Consulting and Clinical Psychology 68 (2000) 31-45
5. Antoni M.H., Wagner S., Cruess D., Kumar M., Lutgendorf S., Ironson G., Dettmer E., Williams J., Klimas N., Fletcher M.A., and Schneiderman N. Cognitive behavioral stress management reduces distress and 24-hour urinary free cortisol among symptomatic HIV-infected gay men. Annals of Behavioral Medicine 22 (2000) 29-37
6. Bangsberg D.R., Hecht F.M., Charlebois E.D., Zolopa A.R., Holodniy M.G., Sheiner L., Bamberger J.D., Chesney M.A., and Moss A. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 14 (2000) 357-366
7. Bing E.G., Burnam M.A., Longshore D., Fleishman J.A., Sherbourne C.D., London A.S., Turner B.J., Eggan F., Beckman R., Vitiello B., Morton S.C., Orlando M., Bozette S.A., Ortiz-Barron L., and Shapiro M. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of General Psychiatry 58 (2001) 721-728
8. Carroll K.M., and Rounsaville B.J. Bridging the gap: A hybrid model to link efficacy and effectiveness research in substance abuse treatment. Psychiatric Services 54 (2003) 333-339
9. Castillo E., Palepu A., Beardsell A., Akagi L., Yip B., Montaner J.S., and Hogg R.S. Outpatient pharmacy care and HIV viral load response among patients on HAART. AIDS Care 16 (2004) 446-457
10. Catz S., Gore-Felton C., and McClure J. Psychological distress among minority and low-income women living with HIV. Behavioral Medicine 28 (2002) 53-60
11. Catz S.L., Kelly J.A., Bogart L.M., Benotsch E.G., and McAuliffe T.L. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology 19 (2000) 124-133
12. Chesney M.A., Ickovics J.R., Chambers D.B., Gifford A.L., Neidig J., Zwickl B., and Wu A.W. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. AIDS Care 12 (2000) 255-266
13. Cruess S., Antoni M.H., Cruess D., Fletcher M.A., Ironson G., Kumar M., Lutgendorf S., Hayes A., Klimas N., and Schneiderman N. Reductions in HSV-2 antibody titers after cognitive-behavioral stress management and relationships with neuroendocrine function, relaxation skills, and social support in HIV+ gay men. Psychosomatic Medicine 62 (2000) 828-837
14. Cruess D., Antoni M.H., Schneiderman N., Ironson G., McCabe P., Fernandez J., Wagner S., Klimas N., and Kumar M. Cognitive-behavioral stress management increases free testosterone and decreases psychological distress in HIV seropositive men. Health Psychology 19 (2000) 12-20
15. Hammer S.M., Saag M.S., and Schecter M. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. Journal of the American Medical Association (2006) 827-843
16. Ibanez G.E., Purcell D.W., Stall R., Parsons J.T., and Gomez C.A. Sexual risk, substance use, and psychological distress in HIV-positive gay and bisexual men who also inject drugs. AIDS 19 (2005) S49-S55
17. Ickovics J.R., Hamburger M.E., Vlahov D., Schoenbaum E.E., Schuman P., Boland R.J., and Moore J. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: Longitudinal analysis from the HIV Epidemiology Research Study. Journal of the American Medical Association 285 (2001) 1460-1465
18. Ironson G., Balbin E., Stuetzle R., Fletcher M.A., O'Cleirigh C., Laurenceau J.P., Schneiderman N., and Solomon G. Dispositional optimism and the mechanisms by which it predicts slower disease progression in HIV: Proactive behavior, avoidant coping, and depression. International Journal of Behavioral Medicine 12 (2005) 86-97
19. Ironson G., O'Cleirigh C., Fletcher M.A., Laurenceau J.P., Balbin E., Klimas N., Schneiderman N., and Solomon G. Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosomatic Medicine 67 (2005) 1013-1021
20. Ironson G., O'Cleirigh C., Weiss A., Schneiderman N., and Costa Jr. P. Personality and HIV disease progression: The role of NEO-PI-R Openness, Extraversion and profiles of engagement. Psychosomatic Medicine 70 (2008) 245-253
21. Kimerling R., Calhoun K.S., Forehand R., Armistead L., Morse E., Morse P., et al. Traumatic stress in HIV-infected women. AIDS Education and Prevention 11 (1999) 321-330
22. Kitahata M.M., Reed S.D., Dillingham P.W., Van Rompaey S.E., Young A.A., Harrington R.D., and Holmes K.K. Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death. International Journal of STD and AIDS 15 (2004) 803-810
23. Leserman J. HIV disease progression: Depression, stress, and possible mechanisms. Biological Psychiatry 54 (2003) 295-306
24. Leserman J., Pence B.W., Whetten K., Mugavero M.J., Thielman N.M., Swartz M.S., and Stangl D. Relation of lifetime trauma and depressive symptoms to mortality in HIV. American Journal of Psychiatry 164 (2007) 1707-1713
25. Leserman J., Whetten J., Lowe K., Stangl D., Swartz M.S., and Thielman N.M. How trauma, recent stressful events, and PTSD affect functional health status and health utilization in HIV-infected patients in the South. Psychosomatic Medicine 67 (2005) 500-507
26. Lutgendorf S., Antoni M.H., Ironson G., Klimas N., Starr K., McCabe P., et al. Cognitive-behavioral stress management decreases dysphoric mood and herpes simplex virus-Type 2 antibody titers in symptomatic HIV-seropositive gay men. Journal of Consulting and Clinical Psychology 65 (1997) 31-43
27. Mugavero M., Ostermann J., Whetten K., Leserman J., Swartz M., Stangl D., and Thielman N. Barriers to antiretroviral adherence: The importance of depression, abuse, and other traumatic events. AIDS Patient Care STDS 20 (2006) 418-428
28. O'Cleirigh C., Hart T.A., and James C.A. HIV and anxiety. In: Zvolensky M.J., and Smits J.A.J. (Eds). Health behaviors and physical illness in anxiety and its disorders: Contemporary theory and research (2007), Springer, New York 317-340
29. O'Cleirigh C., Ironson G., and Smits J. Does distress tolerance moderate the impact of major life events on psychosocial variables and behaviors important in the management of HIV?. Behavior Therapy 38 (2007) 314-323
30. O'Cleirigh C., and Safren S. Breaking the mold or business as usual? Meeting the challenges of HIV prevention in people with serious mental illness and substance use disorders. Clinical Psychology Science and Practice 14 (2007) 34-38
31. Panel on Antiretroviral Guidelines for Adults and Adolescents. Panel guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents (2006), U.S. Department of Health and Human Services, Washington, DC. http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf Accessed October 10, 2006, from http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf
32. Panel on Antiretroviral Guidelines for Adults and Adolescents. Updated guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents (2008, January 29), U.S. Department of Health and Human Services, Washington, DC. http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf Accessed December 1, 2007, at http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf
33. Pence B.W., Miller W.C., Whetten K., Eron J.J., and Gaynes B.N. Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the southeastern United States. Journal of Acquired Immune Deficiency Syndrome 42 (2006) 298-306
34. Petrie K.J., Fontanilla I., Thomas M.G., Booth R.J., and Pennebaker J.W. Effect of written emotional expression on immune function in patients with human immunodeficiency virus infection: a randomized trial. Psychosomatic Medicine 66 (2004) 272-275
35. Safren S.A., Hendriksen E.S., Mayer K.H., Pickard R., and Otto M.W. Cognitive-behavioral therapy for HIV medication adherence and depression. Cognitive and Behavioral Practice 11 (2003) 415-424
36. Safren, S. A., O'Cleirigh, C. O., Tan, J., Raminani, S., Reilly, L., Otto, M. W., & Mayer, K. H. (in press). A randomized controlled trial of cognitive-behavioral therapy for adherence. Health Psychology
37. Safren S.A., Otto M.W., Worth J., Salomon E., Johnson W., Mayer K., and Boswell S. Two strategies to increase adherence to HIV antiretroviral medication: Life-steps and medication monitoring. Behavioural Research and Therapy 39 (2001) 1151-1162
38. Scott-Sheldon L.A., Kalichman S.C., Carey M.P., and Fielder R.L. Stress management interventions for HIV+ adults: A meta-analysis of randomized controlled trials, 1989 to 2006. Health Psychology (2008)
39. Siegel K., Schrimshaw E.W., and Pretter S. Stress-related growth among women living with HIV/AIDS: Examination of an explanatory model. Journal of Behavioral Medicine 28 (2005) 403-414
40. Sikkema K., Kochman A., DiFranceisco W., Kelly J., and Hoffman R. AIDS-related grief and coping with loss among HIV-positive men and women. Journal of Behavioral Medicine 26 (2003) 165-181
41. Soroudi, N., Perez, G. K., Gonzalez, J. S., Greer, J. A., Pollack, M. H., Otto, M. W., Safren, S. A. (in press). CBT for medication adherence and depression (CBT-AD) in HIV-infected individuals receiving methadone maintenance therapy. Cognitive and Behavioral Practice
42. Vanable P.A., Carey M.P., Blair D.C., and Littlewood R.A. Impact of HIV-related stigma on health behaviors and psychological adjustment among HIV-positive men and women. AIDS and Behavior 10 (2006) 473-482